Clinical Trial

Pilot Randomized Study for Treatment Volume De-Escalation for Spinal Metastases With Stereotactic Body Radiation Therapy

Study acronym: REVOL-SPINE
Recruiting
View on ClinicalTrials.gov →
Summary
A single centre, non-profit, randomised, unblinded pilot study on volume definition for spinal stereotactic body radiation therapy treatment. Randomization will be 1:1 between two types of SBRT treatment for spinal metastases. The statistical unit will be the individual vertebral metastasis. Multiple metastases will be randomized and evaluated independently.
Trial Details
NCT Number NCT07538024
Lead Sponsor IRCCS Sacro Cuore Don Calabria di Negrar
Conditions Metastases to Bone
Enrollment 100 participants
Start Date 2025-11-04
Primary Completion 2029-05-04 (estimated)
Study Completion 2029-05-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-20